Academic Geriatric Resource Center
Increase Font Size

AT A GLANCE

Glossary

0. Introduction
1. Demography And Epidemiology
1.1 The Changing Face of Aging: Objectives
1.2 Local and Regional Variations Among Older Adults in the United States
1.3 Implications of an Aging Society for Health Care Needs and Resources
1.4 Common Chronic Conditions Associated with Advanced Age
1.5 Post Test
2. Biology and Physiology of Aging
2.1 Introduction and Background
2.2 Theories of Aging
2.3 Physiological Changes with Aging
2.3.1 Loss of Homeostatic Reserve--Hyperthermia
2.3.2 Loss of Homeostatic Reserve--Hypothermia
2.3.3 Vulnerability of Older Adults to Hypothermia
2.3.4 Clinical Importance of Vulnerability to Hypothermia
2.3.5 Loss of Homeostatic Reserve--Other Examples and Clinical Implications
2.3.6 Clinically Important Age-Related Changes in Organ Systems
2.3.7 Clinically Important Age-Related Changes in the Renal System
2.3.8 Clinical Significance of Age-Related Changes in Renal System
2.3.9 Clinically Important Age-Related Changes in the Cardiovascular System
2.3.10 Clinical Significance of Age-Related Changes in the Cardiovascular System
2.3.11 Clinically Important Age-Related Changes in the Pulmonary System
2.3.12 Clinical Significance of Age-Related Changes in the Pulmonary System
2.3.13 Age-Related Changes in the Neurologic System
2.3.14 Clinical Significance of Age-Related Changes in the Neurologic System (I)
2.3.15 Clinical Significance of Age-Related Changes in the Neurologic System (II)
2.3.16 Clinically Important Age-Related Changes in the Gastrointestinal System
2.3.17 Clinical Significance of Age-Related Changes in the Gastrointestinal System (I)
2.3.18 Clinical Significance of Age-Related Changes in the Gastrointestinal System (II)
2.3.19 Clinically Important Age-Related Changes in the Immune System
2.3.20 Clinical Significance of Age-Related Changes in the Immune System
2.3.21 Clinically Important Age-Related Changes in the Endocrine System (I)
2.3.22 Clinically Important Age-Related Changes in the Endocrine System (II)
2.3.23 Clinical Significance of Age-Related Changes in the Endocrine System
2.3.24 Clinically Important Age-Related Changes in the Musculoskeletal System
2.3.25 Clinical Significance of Age-Related Changes in the Musculoskeletal System (I)
2.3.26 Clinical Significance of Age-Related Changes in the Musculoskeletal System (II)
2.3.27 Clinically Important Age-Related Changes in the Genitourinary System (I)
2.3.28 Clinically Important Age-Related Changes in the Genitourinary System (II)
2.3.29 Clinical Significance of Age-Related Changes in the Genitourinary System
2.3.30 Clinically Important Age-Related Changes in the Sensory Systems
2.3.31 Clinical Significance of Age-Related Changes in the Sensory Systems (I)
2.3.32 Clinical Significance of Age-Related Changes in the Sensory Systems (II)
2.3.33 Clinically Important Age-Related Changes in the Integument
2.3.34 Clinical Significance of Age-Related Changes in the Integument
2.4 Pharmacologic Considerations
2.5 Post Test
3. Socio-cultural And Psychologicial…
3.1 Module Objectives
3.2 Social Theories of Aging
3.3 Psychological Development In Late Life
3.4 Ethno-Cultural Issues And Age-Stratified Societies
3.5 Late-Life Transitions
3.6 Dependent Elders: Special Concerns
3.7 Cultural Views of Death
3.8 References
3.9 Post Test
4. Assessment Of The Geriatric…
4.1 Module Objectives
4.2 Domains of Assessment: Functional Assessment
4.2.1 How to Use Information from a Functional Assessment
4.2.2 Vision Impairment
4.2.3 Hearing Impairment (I)
4.2.4 Hearing Impairment (II)
4.2.5 Oral and Dental Health
4.2.6 Introduction to Oral Health Assessment
4.2.7 Oral Health Assessment
4.2.8 Common Oral Conditions in Older Adults: Tooth Loss (I)
4.2.9 Common Oral Conditions in Older Adults: Tooth Loss (II)
4.2.10 Common Oral Conditions in Older Adults: Care of Dentures
4.2.11 Common Oral Conditions in Older Adults: Dental Decay
4.2.12 Common Oral Conditions in Older Adults: Periodontal Disease
4.2.13 Common Oral Conditions in Older Adults: Candidiasis Infection
4.2.14 Common Oral Conditions in Older Adults: Leukoplakia and the Risk for Oral Cancer
4.2.15 Guidelines for a Dental Referral
4.2.16 Falls and Gait Assessment
4.2.17 Assessing for Falls
4.2.18 Techniques for Gait Assessment
4.2.19 Gait Assessments and Falls Interventions
4.2.20 Risk Factors for Falls and Targeted Interventions
4.2.21 Modification of Risk Factors: Ability to Get Up After a Fall
4.2.22 Modification of Risk Factors: Fracture Risk
4.2.23 Modification of Risk Factors: Anticoagulation
4.2.24 Incontinence
4.2.25 Skin Breakdown: Pressure Ulcers
4.2.26 Cognition/Dementia
4.2.27 Benefits of Early Detection of Dementia
4.2.28 Screening Techniques for Dementia
4.2.29 Decision-Making about Dementia Screening
4.2.30 Nutrition
4.2.31 Alcohol Use and Alcoholism
4.2.32 Medication and Complementary Therapies
4.2.33 Case Example: Mr. Singh
4.2.34 Mr. Singh--Use of Herbal Medicines
4.2.35 Mr. Singh--Possible Interventions
4.2.36 Mr. Singh--Concerns about Marathon Running at 92?
4.2.37 Mr. Singh--Considerations for Patient/Family Well-Being
4.2.38 Assessing for Polypharmacy (I)
4.2.39 Assessing for Polypharmacy (II)
4.3 Domains Of Assessment: Psychosocial Health And Functioning
4.4 Special Considerations In Assessment
4.5 Post Test
5. Health Care Policies
5.1 Module Objectives
5.2 The Policy-Making Process
5.3 Financing Health & Long Term Care
5.4 Quality Of Care Issues In Long Term Care
5.5 Need And Access Across The Spectrum Of Care
5.6 References
5.7 Post Test
6. Exploring Age-Related Body…
6.1 Cardiovascular System
6.2 Endocrine System
6.3 Immune System
6.4 Musculo-Skeletal System
6.5 Neurological System
6.6 Renal System
6.7 Post Test

Module 2: Biology and Physiology of Aging

2.4: Pharmacologic Considerations



2.4.16: References

Abrass, I.B. (1999). Disorders of temperature regulation. In W.R. Hazzard, J.P. Blass, W.H. Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp. 1437-1441). New York, New York: McGraw-Hill.

Ahmed, A., & Tollefsbol, T. (2001). Telomeres and telomerase: Basic science implications for aging. Journal of the American Geriatrics Society, 49(8), 1105-1109.

Beck, L. H. (1999). Aging changes in renal function. In W.R. Hazzard, J.P. Blass, W.H.

Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp.767-776). New York, New York: McGraw-Hill.

Beierle, I., Meibohm, B., & Derendorf, H. (1999). Gender differences in pharmacokinetics and pharmacodynamics. International Journal of Clinical Pharmacology and Therapeutics, 37(11), 529-547.

Cardinali, D.P., Brusco, L.I., Liberczuk, C., & Furio, A.M. (2002). The use of melatonin in Alzheimer’s disease. Neuroendocrine Letters, 23(Suppl 1), 20-23.

Dröge, W. (2002). Free radicals in the physiological control of cell function. Physiological Reviews, 82(1), 47-95.

Enright, P.L. (1999). Aging of the respiratory system. In W.R. Hazzard, J.P. Blass, W.H.

Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp.721-728). New York, New York: McGraw-Hill.

Fenske, N.A., & Lober, C.W. (1986). Structural and functional changes of normal aging skin. Journal of the American Academy of Dermatology, 15(4 Pt 1), 571-585.

Ferriolli, E., Oliveira, R.B., Matsuda, N.M., Braga, F.J., & Dantas, R.O. (1998). Aging, esophageal motility, and gastroesophageal reflux. Journal of the American Geriatrics Society, 46(12), 1534-1537.

Gilchrest, B.A. (1982). Age-associated changes in the skin. Journal of the American Geriatrics Society, 30(2), 139-143.

Gilchrest, B.A. (1999). Dermatologic diseases and disorders. In E.L. Cobbs, E.H. Duthie, & J.B. Murphy (Eds.), Geriatric review syllabus: A core curriculum in geriatric medicine. (pp. 294-300). Debuque, Iowa: Kendall/Hunt Publishing Company fo rthe American Geriatrics Society.

Gleiter, C.H., & Gundert-Remy, U. (1996). Gender differences in pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics, 21(2), 123-128.

Goldschmiedt, M., Barnett, C.C., Schwarz, B.E., Karnes, W.E., Redfern, J.S., & Feldman, M.

(1991). Effect of age on gastric secretion and serum gastrin concentrations in healthy men and Women. Gastroenterology, 101, 977-990.

Grandison, M.K., & Boudinot, F.D. (1991). Age-related changes in protein binding of drugs: implications for therapy. Clinical Pharmacokinetics, 38(3), 271-290.

Grond, S., Radbruch, L., & Lehmann, K.A. (2000). Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clinical Pharmacokinetics, 38(1), 59-89.

Gruenewalks, D.A., & Matsumoto, A.M. (1999). Aging of the endocrine system. In W.R. Hazzard, J.P. Blass, W.H. Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp. 949-966). New York, New York: McGraw-Hill.

Guarente, L, & Kenyon, C. (2000). Genetic pathways that regulate ageing in model organisms. Nature, 408(6809), 255-262.

Gubbins, P.O., & Bertch, K.E., (1989) Drug absorption in gastrointestinal disease and surgery. Pharmacotherapy, 5, 285-294.

Harley C.B., & Villeponteau, B. (1995). Telomeres and telomerase in aging and cancer. Current Opinion in Genetics & Development, 5(2), 249-255.

Hayflick, L. (1980). The cell biology of human aging. Scientific American, 242(1), 58-65.

Hurwitz A., Brady D.A., Schaal S.E., Samloff I.M., Dedon J., & Ruhl C.E. (1997). Gastric acidity in older adults. Journal of the American Medical Association, 278(8), 659-662.

Kristal, B.S. & Yu, B.P. (1992). An emerging hypothesis: Synergistic induction of aging by free radicals and Maillard reactions. Journal of Gerontology: Biological Sciences, 47(4), B107-B114.

Lakatta, E. (1999). Circulatory function in younger and older humans in health. In W.R. Hazzard, J.P. Blass, W.H. Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp. 645-550). New York, New York: McGraw-Hill.

Larsen, P.L., Albert, P.S., & Riddle, D.L. (1995). Genes that regulate both development and longevity in Caenorhabditis Elegans. Genetics, 139(4), 1567-1583.

Lee, C.K., Klopp, R.G., Weindruch, R., & Prolla, T.A. (1999). Gene expression profile of aging and its retardation by caloric restriction. Science, 285(5432), 1390-1393.

Lipsitz, L.A., & Goldberger, A.L. (1992). Loss of complexity and aging. Potential applications and chaos theory to senescence. Journal of the American Medical Association, 267(13), 1806-1809.

Lissoni, P. (2002). Is there a role for melatonin in supportive care? Supportive Care in Cancer, 10(2), 110-116.

Loeser, R.F., & Delbono, O. (1999). Aging and the musculoskeletal system. In W.R. Hazzard, J.P. Blass, W.H. Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp. 1097-1111). New York, New York: McGraw-Hill.

Marcotte, R., & Wang, E. (2002). Replicative senescence revisited. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 57A(7), B257-B269.

Masoro, E.J. (Ed.). (2001). Caloric restriction’s effects on aging: Opportunities for research on human implications. [Special issue]. Journals of Gerontology: Series A, Biological Sciences and Medical Sciences, 56A(3, Suppl.1).

Mattson, M.P. (1999). Cellular and neurochemical aspects of the aging human brain. In W.R. Hazzard, J.P. Blass, W.H. Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp. 1193-1208). New York, New York: McGraw-Hill.

Miller, R.A. (1999). Biology of aging and longevity. In W.R. Hazzard, J.P. Blass, W.H. Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp. 3-19). New York, New York: McGraw-Hill.

Monnier, V.M. (1990). Minireview: Nonenzymatic glycosylation, the Maillard Reaction and the aging process. Journals of Gerontology: Series A, Biological Sciences and Medical Sciences, 45(4), B105-B111.

Muijsers, R.B., & Wagstaff, A.J. (2001). Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs, 61(15), 2289-2307.

Murasko, D., & Bernstein, E. (1999). Immunology of aging. In W.R. Hazzard, J.P. Blass, W.H. Ettinger, J.B. Halter, & J.G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp. 97-116). New York, New York: McGraw-Hill.

Okatani, Y., Wakatsuki, A., Shinohara, K., Kaneda, C., & Fukaya, T. (2001). Melatonin stimulates glutathione peroxidase activity in human chorion. Journal of Pineal Research, 30(4), 199-205.

Pandi-Perumal, S.R., Seils, L.K., Kayumov, L., Ralph, M.R., Lowe, A., Moller, H., & Swaab, D.F. (2002). Senescence, sleep, and circadian rhythms. Ageing Research Reviews, 1(3), 559-604.

Puca, A.A., Daly, M.J., Brewster, S.J., Matise, T.C., Barrett, J., Shea-Drinkwater, M., Kang, S., Joyce, E., Nicoli, J., Benson, E., Kunkel, L.M., & Perls, T. (2001). A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proceedings of the National Academy of Sciences, 98(18), 10505-10508.

Reiter, R.J., Tan, D.X., & Burkhardt, S. (2002). Reactive oxygen and nitrogen species and cellular and organismal decline: Amelioration with melatonin. Mechanisms of Ageing and Development, 123(8), 1007-1019.

Reuben, D.B., Herr, K., Pacala, J.T., Potter, J.F., Semla, T.P., & Small, G.W. (2001). Geriatrics at Your Fingertips. Bele Mead, New Jersy: Excerpta Medica.

Rose, M.R. & Mueller, L.D. (1998). Evolution of human lifespan: Past, future, and present. American Journal of Human Biology, 10, 409-420.

Rose, M.R. (1991). Evolutionary biology of aging. New York: Oxford University Press.

Rowe, J.W. & Kahn, R.L. (1998). Successful aging. The Gerontologist, 37(4), 433-440.

Russell, R.M. (2000). The aging process as a modifier of metabolism. American Journal of Clinical Nutrition, 72(2 Suppl), 529S-532S.

Shay, K., (1999). Oral disease and disorders. In E.L. Cobbs, E.H. Duthie, & J.B. Murphy (Eds.), Geriatric review syllabus: A core curriculum in geriatric medicine. (pp. 245-249). Debuque, Iowa: Kendall/Hunt Publishing Company fo rthe American Geriatrics Society.

Shulman, R.W., & Özdemir, V. (1997). Psychotropic Medications and Cytochrome P450 2D6: Pharmacokinetic Considerations in the Elderly. Canadian Journal of Psychiatry, 42(5 Suppl), 4S-9S.

Smythe, M., Hoffman, J., Kizy, K., & Dmuchowski, C. (1994). Estimating creatinine clearance in elderly patients with low serum creatinine concentrations. American Journal of Hospital Pharmacy, 51(2), 198-204.

Thompson, J.P., Bower, S., Liddle, A.M., & Rowbotham, D.J. (1998). Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients. British Journal of Anaesthesiology, 2, L152-154.

Van Hoogdalem, E., de Boer, A.G., & Breimer D.D. (1991). Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clinical Pharmacokinetics, 21(1), 11-26.

Watson, W.A., Sands, M.F., Balow, J.C., Lener, M.E., & Wilton, J.H. (1991). Lidocaine absorption and metabolism after oropharyngeal application in young and young-elderly adults. Annals of Pharmacotherapy, 25(5), 463-465.

 


Module 2: Biology and Physiology of Aging
2.4.15 Profile of the Elder…
2.5 Post Test